首页> 中文期刊> 《中南药学》 >信迪利单抗致甲状腺功能减退和糖尿病酮症酸中毒1例

信迪利单抗致甲状腺功能减退和糖尿病酮症酸中毒1例

         

摘要

<正>信迪利单抗是作用于程序性细胞死亡蛋白1(PD-1)及其配体的一种Ig G4单克隆抗体,它能有效地与PD-1结合,干扰PD-1与其配体(PD-L1和PD-L2)的相互作用,从而激活和恢复T细胞的功能,具有明显的抗肿瘤作用[1]。信迪利单抗已于2018年12月获国家药品监督管理局批准用于治疗接受过二线或以上全身化疗的复发或难治性经典霍奇金淋巴瘤患者[1-2],并于2021年6月获批了肝癌、

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
  • 机译:致编辑的信:是否存在用于切换英夫利昔单抗的作用,以便在有源炎症肠病病例中重新获得抗TNF响应?

  • 机译:信:IBD患者中止英夫利昔单抗后抗英夫利昔单抗抗体的持久性

  • 机译:对编辑信的回应:“对克罗恩病失丧对荷马单抗失去反应后对英夫利昔单抗的回应”

  • 机译:具有抗利妥昔单抗的B细胞淋巴瘤的有效抗肿瘤活性的利妥昔单抗变体的表征

  • 机译:增强利妥昔单抗治疗:分析利妥昔单抗与人类补体途径之间的相互作用。

  • 机译:英夫利昔单抗致甲状腺功能减退:一种新的病例和有关机制的假设。

  • 机译:伽利略在罗马致卢多维科·卡迪·德·希科利的信</span> </p> </li> <li> <div> <b>8. </b><a class="enjiyixqcontent" href="/ntis-science-report_de_thesis/02071899022.html">Proposed letter to Hans Blix, Director General of the IAEA</a> <b>[R] </b> . <span> <a href="/search.html?doctypes=4_5_6_1-0_4-0_1_2_3_7_9&sertext=&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor"> </a> <span>1994</span> </span> </div> <p class="zwjiyix translation" style="max-width: initial;height: auto;word-break: break-all;white-space: initial;text-overflow: initial;overflow: initial;"> <span>机译:致国际原子能机构总干事汉斯·布利克斯的信</span> </p> </li> </ul> <ul style="display: none;"> <li> <div> <b>1. </b><a class="enjiyixqcontent" href="/patent-detail/06120111181993.html">具有降低的ADCP的奥滨尤妥珠单抗和利妥昔单抗变体</a> <b>[P]</b> . <span> 中国专利: CN108699156A </span> <span> . 2018-10-23</span> </div> </li> <li> <div> <b>2. </b><a class="enjiyixqcontent" href="/patent-detail/06120114220119.html">跨迪链征信数据加密存储及信用评分隐私计算方案</a> <b>[P]</b> . <span> 中国专利: CN114338043A </span> <span> . 2022-04-12</span> </div> </li> <li> <div> <b>3. </b><a class="enjiyixqcontent" href="/patent-detail/06130435331168.html">method of treating non-hodgkin's lymphoma in a mammal, uses a combination of cci-779 and rituximab and a combination of a mtor and rituximab inhibitor, products containing cci-779 and rituximab and a mtor and rituximab inhibitor, pharmaceutical packaging and pharmaceutical composition</a> <b>[P]</b> . <span> 外国专利: <!-- --> BRPI0508451A </span> <span> . 2007-07-24</span> </div> <p class="zwjiyix translation" style="max-width: initial;height: auto;word-break: break-all;white-space: initial;text-overflow: initial;overflow: initial;"> <span>机译:治疗哺乳动物非霍奇金淋巴瘤的方法,使用cci-779和利妥昔单抗的组合以及mtor和利妥昔单抗抑制剂的组合,包含cci-779和利妥昔单抗以及mtor和利妥昔单抗抑制剂的产品,药物包装和药物组合物 </span> </p> </li> <li> <div> <b>4. </b><a class="enjiyixqcontent" href="/patent-detail/06130400531327.html">TREATMENT OF NECHODGKIN'S LYMPHOMA WITH LILOTOMAB AND 177Lu-LILOTOMAB WITH SATETHRAXETAN</a> <b>[P]</b> . <span> 外国专利: <!-- 俄罗斯专利: --> RU2019110955A </span> <span> . 2020-10-20</span> </div> <p class="zwjiyix translation" style="max-width: initial;height: auto;word-break: break-all;white-space: initial;text-overflow: initial;overflow: initial;"> <span>机译:利妥昔单抗和177Lu-利洛妥单抗联合赛妥昔单抗治疗尼古丁氏淋巴瘤 </span> </p> </li> <li> <div> <b>5. </b><a class="enjiyixqcontent" href="/patent-detail/06130501534224.html">COMBINATION OF MONALIZUMAB, DURVALUMAB, CHEMOTHERAPY AND BEVACIZUMAB OR CETUXIMAB FOR THE TREATMENT OF COLORECTAL CANCER</a> <b>[P]</b> . <span> 外国专利: <!-- 欧洲知识产权局专利: --> EP3965816A1 </span> <span> . 2022-03-16</span> </div> <p class="zwjiyix translation" style="max-width: initial;height: auto;word-break: break-all;white-space: initial;text-overflow: initial;overflow: initial;"> <span>机译:莫那利珠单抗、杜鲁单抗、化疗和贝伐单抗或西妥昔单抗联合治疗结直肠癌 </span> </p> </li> </ul> </div> </div> </div> <div class="theme cardcommon" style="overflow: auto;display:none"> <h3 class="all_title" id="enpatent55">相关主题</h3> <ul id="subject"> </ul> </div> </div> </div> </div> <div class="right rightcon"> <div class="details_img cardcommon clearfix" > </div> </div> </div> <div id="thesis_get_original1" class="downloadBth" style="bottom: 19px;z-index: 999;" onclick="xz('02012107454980','1',2,1,this,4,0)" title="文献原文发送到邮箱" prompt="010101">获取原文</div> <div class="journalsub-pop-up" style="display: none"> <div class="journal-sub"> <h2>期刊订阅</h2> <img src="https://cdn.zhangqiaokeyan.com/img/loginclose.png" alt="" onclick="$('.journalsub-pop-up').hide()"> <p class="pardon">抱歉,该期刊暂不可订阅,敬请期待!</p> <p class="current">目前支持订阅全部北京大学中文核心(2020)期刊目录。</p> <div style="display: flex;margin-top: 69px;justify-content: space-between;"> <div class="no-sub" onclick="$('.journalsub-pop-up').hide()">暂不订阅</div> <div class="other-sub" onclick="continueSub('from=pc-detail')">继续订阅其他期刊</div> </div> </div> </div> <div class="right_btn"> <ul> <li class="gouwuche"> <!-- <a href="javascript:void(0);" onclick="link_analysis('/shoppingcart/auth/list.html',this)">购物车</a>--> </li> <li class="yijian"> <a href="javascript:void(0);" onclick="link_analysis('/mycenter/auth/complaint.html',this)">意见反馈</a> </li> <li class="top"> <a href="javascript:scrollTo(0,0);">回到顶部</a> </li> <li class="shouye"> <a href="/">回到首页</a> </li> </ul> </div> <div class="xllindexfooter"> <div class="xllindexfootercenter"> <div class="xllindexfooterleft left" > <div class="xllindexfooterleftli"> <ul> <li><a href="/about.html">关于掌桥</a></li> <li><a href="/help/helpmap.html">资源导航</a></li> <li><a href="/help/helpguide.html">新手指南</a></li> <li><a href="/help/helpcenter.html">常见问题</a></li> <li><a href="/sitemap.html">网站地图</a></li> <li><a href="/help/helpcenter.html?type=9">版权声明</a></li> </ul> </div> <div class="xllindexfooterleft"> <p class="xllindexfooterlefteamil">客服邮箱:kefu@zhangqiaokeyan.com</p> <div class="xllindexfooterlefttcp"> <div class="xllindexfooterpoliceiimg"></div> <div class="xllindexfooterpoliceispan"> <span>京公网安备:11010802029741号 </span> <span>ICP备案号:<a href="https://beian.miit.gov.cn" rel="nofollow" target="_blank">京ICP备15016152号-6</a></span> <span>六维联合信息科技 (北京) 有限公司©版权所有</span> </div> </div> </div> </div> <div class="xllindexfooterright left"> <ul> <li> <p style="font-weight: bold;">客服微信</p> <div></div> </li> <li> <p style="font-weight: bold;">服务号</p> <div></div> </li> </ul> </div> </div> </div> <span id="02012107454980down" data-source="11," data-out-id="ZNYX202302044," data-f-source-id="2" data-title="信迪利单抗致甲状腺功能减退和糖尿病酮症酸中毒1例" data-price="10" data-site-name="" data-transnum="0" style="display:none;"></span> <input type="hidden" value="1" id="sourcetype"> <input type="hidden" value="56883" id="journalid"> <input type="hidden" value="1" id="inyn_provide_service_level"> <input type="hidden" value="https://cdn.zhangqiaokeyan.com" id="imgcdn"> <input type="hidden" value="1" id="isdeatail"> <input type="hidden" value="" id="syyn_indexed_database"> <input type="hidden" value="201-1_" id="servicetype"> <input type="hidden" id="pagename" value="信迪利单抗致甲状腺功能减退和糖尿病酮症酸中毒1例"/> <input type="hidden" value="thesis_get_original" id="pageIdentification"> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/jquery-1.12.4.js"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/common/lwlh_ajax.js"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/zq.js?v=5.7.7"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/common/common.js?v=5.7.7"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/jquery.cookie.js"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/top.js?v=5.7.7"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/common/tip.js?v=5.7.7"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/common/login.js?v=5.7.7"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/common/down.js?v=5.7.7"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/common/search.js?v=5.7.7"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/searchtype.js?v=5.7.7"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/user/regist.js?v=5.7.7"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/zxs_solor/detail.js?v=5.7.7"></script> <script type="text/javascript" src="https://www.zhangqiaokeyan.com/statistics/static/pagecollection.js"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/tj.js"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/pushbaidu.js"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/common/history.js"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/util/cookie.js?v=5.7.7"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/weipu/weipu.js?v=5.7.7"></script> </body> <script> $(function(){ var weiPuStatus = getCookie('WeiPuStatus'); if(weiPuStatus){ tipWeiPuStatus(weiPuStatus); delCookie('WeiPuStatus'); } getFacetKeywordVoInId(); var sourcetype = $("#sourcetype").val(); var inyn_provide_service_level = $("#inyn_provide_service_level").val(); if((sourcetype ==1||sourcetype==4)&&inyn_provide_service_level!=4){ getJournal(); } }) </script> </html>